Radius Health saw the highest growth of 3.99% in patent filings in May and 1.99% in grants in April in Q2 2024. Compared to Q1 2024, Q2 2024 saw an increase in patent filings by 0.32% and grants by 1.99%. GlobalData’s DataBook provides a comprehensive analysis of Radius Health‘s patent filings and grants. Buy the databook here.
Radius Health has been focused on protecting inventions in United States(US) with five publications in Q2 2024
The United States(US) Patent Office dominates the patent filings and grants with nearly 43% filings and 17% grants. The United States(US), Australia(AU), European Patent Office(EPO), and Israel(IL) patent Office are among the top ten patent offices where Radius Health is filings its patents. Among the top granted patent authorities, Radius Health has 33% of its grants in Israel(IL), 25% in Japan(JP) and 17% in United States(US).
Roche and Johnson & Johnson could be the strongest competitors for Radius Health
Patents related to addiction and rare diseases lead Radius Health's portfolio
Radius Health has the highest number of patents in addiction followed by, rare diseases. For addiction no patents were filed and 25% of patents were granted in Q2 2024.
Breast cancer related patents lead Radius Health portfolio followed by petrochemicals, and ovarian cancer
Radius Health has highest number of patents in breast cancer followed by petrochemicals, ovarian cancer, osteoporosis, and prostate cancer. For breast cancer, nearly 9% of patents were filed and 10% of patents were granted in Q2 2024.
For comprehensive analysis of Radius Health's filings and grants, buy the databook here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.